What are the opening hours?

Monday 09:00 - 18:00 Tuesday 09:00 - 18:00 Wednesday 09:00 - 18:00 Thursday 09:00 - 18:00 Friday 09:00 - 18:00

Oncode Scientific Sdn Bhd

Home
Malaysia
Shah Alam
Oncode Scientific Sdn Bhd

Oncode Scientific Sdn Bhd
201501029484 (1154805-X)

Leading the Precision Medicine Revolution in Asia

Since 2015, Oncode Scientific Sdn Bhd has emerged as a trailblazer in the realm of precision medicine, setting new benchmarks in cancer molecular diagnostics. Our multidisciplinary team, comprising top-tier experts from molecular science and clinical practice, brings together decades of experience in medical diagnostics and research. At our cuttin

g-edge facilities in Malaysia, we spearhead one of Asia’s most pioneering precision medicine initiatives, specializing in both solid tumors and hematologic cancers. Our relentless pursuit of innovation drives us to constantly challenge the status quo, exceeding clinical and diagnostic standards to deliver groundbreaking medical solutions. Oncode is dedicated to transforming healthcare—advancing disease prevention, early detection, and targeted intervention. With a commitment to excellence, we provide world-class molecular diagnostic services that are both accessible and revolutionary, empowering the global community to embrace the full potential of precision medicine.

30/04/2026

Behind every breakthrough🔬,
there is work — seen and unseen.

Progress doesn’t happen all at once.
It’s built through consistent effort, day after day.

Today, we recognise the dedication that keeps everything moving forward 💪🏻

Happy Labour Day!

18/04/2026

Head and neck cancers are among the most preventable — yet they remain frequently diagnosed at advanced stages.

Persistent symptoms such as a sore throat, unexplained hoarseness, difficulty swallowing, or a lump in the neck are often attributed to minor conditions. When left unaddressed, delayed attention can lead to diagnosis at more advanced stages, where treatment becomes more complex.

To***co use, alcohol consumption, and HPV infection account for the majority of cases — many of which are preventable with the right awareness and timely action.

Advances in molecular diagnostics now allow clinicians to better classify these cancers, enabling more precise and personalised treatment strategies.

Awareness is the first step.
Timely action is what makes the difference.

14/04/2026

In oncology, 𝗰𝗵𝗼𝗼𝘀𝗶𝗻𝗴 𝘁𝗵𝗲 𝗿𝗶𝗴𝗵𝘁 𝘁𝗲𝘀𝘁 𝗶𝘀 𝗮𝘀 𝗰𝗿𝗶𝘁𝗶𝗰𝗮𝗹 𝗮𝘀 𝗰𝗵𝗼𝗼𝘀𝗶𝗻𝗴 𝘁𝗵𝗲 𝗿𝗶𝗴𝗵𝘁 𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁..

On 7th April 2026, Oncode engaged with the 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆 𝘁𝗲𝗮𝗺 𝗮𝘁 𝗛𝗼𝘀𝗽𝗶𝘁𝗮𝗹 𝗞𝘂𝗮𝗹𝗮 𝗟𝘂𝗺𝗽𝘂𝗿 (𝗛𝗞𝗟) on how 𝗡𝗲𝘅𝘁 𝗚𝗲𝗻𝗲𝗿𝗮𝘁𝗶𝗼𝗻 𝗦𝗲𝗾𝘂𝗲𝗻𝗰𝗶𝗻𝗴 (𝗡𝗚𝗦) is transforming treatment decision-making in solid tumors.

The session provided a detailed comparison of 𝗡𝗚𝗦 𝗮𝗻𝗱 𝗣𝗖𝗥 𝗽𝗮𝗻𝗲𝗹𝘀 in molecular profiling, highlighting their roles in identifying 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹𝗹𝘆 𝗮𝗰𝘁𝗶𝗼𝗻𝗮𝗯𝗹𝗲 𝗶𝗻𝘀𝗶𝗴𝗵𝘁𝘀. A key focus was on 𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗺𝗮𝘁𝗰𝗵𝗶𝗻𝗴 — ensuring physicians select the most relevant test to guide effective therapeutic strategies.

We also introduced 𝗢𝗻𝗰𝗼𝗱𝗲’𝘀 𝗹𝗮𝘁𝗲𝘀𝘁 𝗡𝗚𝗦 𝗽𝗮𝗻𝗲𝗹𝘀, designed with 𝗳𝗹𝗲𝘅𝗶𝗯𝗹𝗲 𝗴𝗲𝗻𝗲 𝗰𝗼𝘃𝗲𝗿𝗮𝗴𝗲 to better align with different solid tumor profiles and clinical needs.

Thank you to the HKL team for the valuable discussions and shared commitment to advancing precision oncology.

13/04/2026

When it comes to acute leukaemia, 𝘁𝗵𝗲 𝗱𝗲𝗽𝘁𝗵 𝗼𝗳 𝗶𝗻𝘀𝗶𝗴𝗵𝘁 𝗱𝗲𝘁𝗲𝗿𝗺𝗶𝗻𝗲𝘀 𝘁𝗵𝗲 𝗱𝗶𝗿𝗲𝗰𝘁𝗶𝗼𝗻 𝗼𝗳 𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁.

On 6th April 2026, Oncode engaged with the 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗛𝗮𝗲𝗺𝗮𝘁𝗼𝗹𝗼𝗴𝘆 𝘁𝗲𝗮𝗺 𝗮𝘁 𝗛𝗼𝘀𝗽𝗶𝘁𝗮𝗹 𝗔𝗺𝗽𝗮𝗻𝗴 on the role of 𝗡𝗲𝘅𝘁 𝗚𝗲𝗻𝗲𝗿𝗮𝘁𝗶𝗼𝗻 𝗦𝗲𝗾𝘂𝗲𝗻𝗰𝗶𝗻𝗴 (𝗡𝗚𝗦) in the 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰 𝗮𝗻𝗱 𝘁𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰 𝗺𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁 𝗼𝗳 𝗯𝗹𝗼𝗼𝗱 𝗰𝗮𝗻𝗰𝗲𝗿𝘀.

The session explored the differences between 𝗣𝗖𝗥 𝗮𝗻𝗱 𝗡𝗚𝗦 𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝗶𝗲𝘀, highlighting how broader molecular profiling supports more precise clinical decisions. Discussions also covered 𝗔𝗠𝗟 𝗳𝘂𝘀𝗶𝗼𝗻 𝗮𝗻𝗱 𝗺𝘂𝘁𝗮𝘁𝗶𝗼𝗻 𝘁𝗲𝘀𝘁𝗶𝗻𝗴, with emphasis on their relevance in guiding targeted therapies.

Real-world 𝗰𝗮𝘀𝗲 𝘀𝘁𝘂𝗱𝗶𝗲𝘀 demonstrated how 𝗺𝗼𝗹𝗲𝗰𝘂𝗹𝗮𝗿 𝗺𝗼𝗻𝗶𝘁𝗼𝗿𝗶𝗻𝗴 continues to shape AML management in practice.

We also introduced our latest advancement — the 𝗜𝗚𝗛𝗩 𝗦𝗼𝗺𝗮𝘁𝗶𝗰 𝗛𝘆𝗽𝗲𝗿𝗺𝘂𝘁𝗮𝘁𝗶𝗼𝗻 𝗡𝗚𝗦 𝗮𝘀𝘀𝗮𝘆, supporting more informed management of 𝗖𝗵𝗿𝗼𝗻𝗶𝗰 𝗟𝘆𝗺𝗽𝗵𝗼𝗰𝘆𝘁𝗶𝗰 𝗟𝗲𝘂𝗸𝗲𝗺𝗶𝗮 (𝗖𝗟𝗟).

Thank you to the Hospital Ampang team for the meaningful exchange and continued commitment to advancing precision haematology.

07/04/2026

On World Health Day 2026, the global focus is clear:
𝗧𝗼𝗴𝗲𝘁𝗵𝗲𝗿 𝗳𝗼𝗿 𝗛𝗲𝗮𝗹𝘁𝗵. 𝗦𝘁𝗮𝗻𝗱 𝘄𝗶𝘁𝗵 𝗦𝗰𝗶𝗲𝗻𝗰𝗲.

As healthcare challenges continue to evolve, the role of science has never been more critical. From preventive medicine to personalised treatment strategies, evidence-based innovation is at the core of better health outcomes.

Advancements in diagnostics, genomics, and precision medicine are reshaping how we understand, prevent, and manage disease — enabling a shift toward more proactive and individualised care.

At the same time, meaningful progress requires collective effort — across healthcare systems, professionals, and communities.

Health is not built in isolation.
It is shaped through collaboration, guided by science, and strengthened by informed action.

07/04/2026

💙 𝐖𝐞 𝐚𝐫𝐞 𝐞𝐱𝐩𝐚𝐧𝐝𝐢𝐧𝐠 𝐨𝐮𝐫 𝐭𝐞𝐚𝐦 𝐚𝐭 𝐎𝐧𝐜𝐨𝐝𝐞!

As a precision oncology diagnostics company, we are committed to advancing cancer care through genomic insights and innovation.

As we continue to grow, we’re looking for passionate and driven individuals to join us in the following roles:

• 𝐌𝐚𝐫𝐤𝐞𝐭𝐢𝐧𝐠 & 𝐂𝐨𝐦𝐦𝐮𝐧𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬 𝐄𝐱𝐞𝐜𝐮𝐭𝐢𝐯𝐞
• 𝐁𝐢𝐨𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐜𝐢𝐚𝐧
• 𝐑&𝐃 𝐒𝐜𝐢𝐞𝐧𝐭𝐢𝐬𝐭
• 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐎𝐟𝐟𝐢𝐜𝐞𝐫

📍 𝐒𝐡𝐚𝐡 𝐀𝐥𝐚𝐦, 𝐒𝐞𝐥𝐚𝐧𝐠𝐨𝐫

📩 𝐊𝐢𝐧𝐝𝐥𝐲 𝐬𝐜𝐚𝐧 𝐭𝐡𝐞 𝐐𝐑 𝐜𝐨𝐝𝐞 𝐭𝐨 𝐬𝐮𝐛𝐦𝐢𝐭 𝐲𝐨𝐮𝐫 𝐚𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐨𝐫 𝐚𝐩𝐩𝐥𝐲 𝐨𝐧𝐥𝐢𝐧𝐞 𝐡𝐞𝐫𝐞: https://lnkd.in/ga3xgKsS

✅𝐏𝐫𝐢𝐨𝐫𝐢𝐭𝐲 𝐰𝐢𝐥𝐥 𝐛𝐞 𝐠𝐢𝐯𝐞𝐧 𝐭𝐨 𝐌𝐚𝐥𝐚𝐲𝐬𝐢𝐚-𝐛𝐚𝐬𝐞𝐝 𝐜𝐚𝐧𝐝𝐢𝐝𝐚𝐭𝐞𝐬.

If you're excited about genomics, innovation, and making real clinical impact, we’d love to hear from you.

01/04/2026

When every genomic insight can change a treatment path, 𝗺𝗶𝘀𝘀𝗶𝗻𝗴 𝗮 𝗺𝘂𝘁𝗮𝘁𝗶𝗼𝗻 𝗶𝘀 𝗻𝗼𝘁 𝗮𝗻 𝗼𝗽𝘁𝗶𝗼𝗻.

On 26 March 2026, Oncode engaged with the 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆 𝗗𝗲𝗽𝗮𝗿𝘁𝗺𝗲𝗻𝘁 𝗮𝘁 𝗨𝗻𝗶𝘃𝗲𝗿𝘀𝗶𝘁𝘆 𝗠𝗮𝗹𝗮𝘆𝗮 𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗖𝗲𝗻𝘁𝗿𝗲 (𝗨𝗠𝗠𝗖) on how 𝗺𝗼𝗹𝗲𝗰𝘂𝗹𝗮𝗿 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀 𝗮𝗿𝗲 𝗿𝗲𝘀𝗵𝗮𝗽𝗶𝗻𝗴 𝗰𝗮𝗻𝗰𝗲𝗿 𝗰𝗮𝗿𝗲.

The discussion centred on a key priority — 𝗶𝗺𝗽𝗿𝗼𝘃𝗶𝗻𝗴 𝘁𝗵𝗲 𝗱𝗲𝘁𝗲𝗰𝘁𝗶𝗼𝗻 𝗼𝗳 𝗮𝗰𝘁𝗶𝗼𝗻𝗮𝗯𝗹𝗲 𝗺𝘂𝘁𝗮𝘁𝗶𝗼𝗻𝘀 𝘁𝗼 𝘀𝘂𝗽𝗽𝗼𝗿𝘁 𝗯𝗲𝘁𝘁𝗲𝗿 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗱𝗲𝗰𝗶𝘀𝗶𝗼𝗻𝘀. Through our 𝗡𝗚𝗦 𝗮𝗻𝗱 𝗣𝗖𝗥 𝗽𝗮𝗻𝗲𝗹𝘀, we deliver 𝗰𝗼𝗺𝗽𝗿𝗲𝗵𝗲𝗻𝘀𝗶𝘃𝗲, 𝗵𝗶𝗴𝗵-𝗾𝘂𝗮𝗹𝗶𝘁𝘆 𝗺𝗼𝗹𝗲𝗰𝘂𝗹𝗮𝗿 𝗽𝗿𝗼𝗳𝗶𝗹𝗶𝗻𝗴 that supports confident, precision-driven decisions in clinical practice.

From 𝗿𝗶𝗴𝗼𝗿𝗼𝘂𝘀 𝘃𝗮𝗹𝗶𝗱𝗮𝘁𝗶𝗼𝗻 to 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹𝗹𝘆 𝗮𝗰𝘁𝗶𝗼𝗻𝗮𝗯𝗹𝗲 𝗿𝗲𝘀𝘂𝗹𝘁𝘀, quality isn’t just a benchmark — it’s our responsibility to every patient.

The session sparked valuable conversations on 𝗶𝗻𝘁𝗲𝗴𝗿𝗮𝘁𝗶𝗻𝗴 𝗺𝗼𝗹𝗲𝗰𝘂𝗹𝗮𝗿 𝘁𝗲𝘀𝘁𝗶𝗻𝗴 𝗶𝗻𝘁𝗼 𝗿𝗼𝘂𝘁𝗶𝗻𝗲 𝗼𝗻𝗰𝗼𝗹𝗼𝗴𝘆 𝘄𝗼𝗿𝗸𝗳𝗹𝗼𝘄𝘀, reinforcing a shared direction:
𝗽𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻, 𝗰𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻, 𝗮𝗻𝗱 𝗯𝗲𝘁𝘁𝗲𝗿 𝗽𝗮𝘁𝗶𝗲𝗻𝘁 𝗼𝘂𝘁𝗰𝗼𝗺𝗲𝘀.

Thank you to the UMMC team for the meaningful exchange.

30/03/2026

𝗖𝗼𝗹𝗼𝗿𝗲𝗰𝘁𝗮𝗹 𝗰𝗮𝗻𝗰𝗲𝗿 is increasingly being diagnosed at younger ages — often without obvious early warning signs.

While symptoms may appear subtle, risk can be present long before they surface. This is why screening, and in some cases genetic evaluation, plays a critical role in early detection and prevention.

Understanding your 𝗶𝗻𝗱𝗶𝘃𝗶𝗱𝘂𝗮𝗹 𝗿𝗶𝘀𝗸 𝗽𝗿𝗼𝗳𝗶𝗹𝗲 — including family history and genetic predisposition — enables a more proactive and personalised approach to care.

Early detection does not only improve outcomes.
It changes them.

🩺 If you fall within a 𝗵𝗶𝗴𝗵𝗲𝗿-𝗿𝗶𝘀𝗸 𝗴𝗿𝗼𝘂𝗽 or have concerns about your health, consider speaking to a healthcare professional about appropriate screening and testing options.

20/03/2026

🕊️ Hari Raya is a time of reflection, forgiveness, and renewal.

As we welcome the blessed month of Syawal, we extend our heartfelt wishes to all who celebrate. Selamat Hari Raya, Maaf Zahir dan Batin.🌿

May this festive season bring you closer to your loved ones and fill your days with joy, peace, and meaningful moments together. May the spirit of Aidilfitri inspire renewed strength, gratitude, and harmony in the days ahead.

19/03/2026

Genetic testing plays an important part in how we understand health, risk, and treatment today.

From identifying inherited risks to guiding cancer care and monitoring disease, genetic insights are helping doctors make more informed, personalized decisions.

But many questions still remain:
Who should get tested?
What can it really tell you?
And just as important—what can’t it tell you?

Understanding these answers is the first step toward making better health decisions—for yourself and your family.

Explore the essentials of genetic testing through our Q&A series.

07/03/2026

Understanding your cancer risk starts with knowing when to test.

Many cancers develop silently — long before symptoms appear. Genetic testing and appropriate screening can help identify risk earlier, allowing doctors to monitor, prevent, or treat cancer more effectively.

Genetic testing may be recommended if you have a personal or family history of cancer, known genetic mutations in the family, or other factors that may increase your risk.

In today’s era of precision medicine, understanding your genetic profile provides valuable insight for early detection, personalised prevention strategies, and more informed healthcare decisions.

Because when it comes to cancer, knowing your risk is the first step toward protecting your health.

If you’re unsure whether genetic testing is right for you, consider speaking with a healthcare professional to explore your options.

06/03/2026

On 12 February, we engaged with the Respiratory Medicine and Laboratory teams at Hospital Raja Permaisuri Bainun for a CME session on the pivotal role of Next Generation Sequencing (NGS) in personalised Non-Small Cell Lung Cancer (NSCLC) care.

The session explored the fundamentals of NGS testing and how genomic biomarkers increasingly shape diagnostic pathways and treatment strategies. Discussions highlighted how comprehensive and sensitive molecular insights can support clinicians in selecting more targeted and personalised therapies for their patients.

Beyond the technology itself, the session also emphasised the importance of best-practice pre-analytical sample handling and preparation, as these critical steps directly influence the accuracy and reliability of NGS results. Strong coordination between clinicians and laboratory teams remains essential to ensure high-quality testing and meaningful clinical interpretation.

As oncology continues to advance towards precision-driven care, close collaboration between diagnostics and clinical teams is key to translating molecular insights into better-informed treatment decisions for patients.

Address

Lot 03-01, 3rd Floor. Hap Seng Business Park, No. 12, Persiaran Perusahaan, Unity Square. Seksyen 23, Shah Alam D. E.
Shah Alam
40300

Opening Hours

Monday	09:00 - 18:00
Tuesday	09:00 - 18:00
Wednesday	09:00 - 18:00
Thursday	09:00 - 18:00
Friday	09:00 - 18:00

Telephone

+60333100819

Website

http://www.oncodesc.com/

Alerts

Be the first to know and let us send you an email when Oncode Scientific Sdn Bhd posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Oncode Scientific Sdn Bhd:

Shortcuts

Address
Telephone
Opening Hours
Alerts
Contact The Practice
Claim ownership or report listing

Want your practice to be the top-listed Clinic in Shah Alam?

Oncode Scientific Sdn Bhd

30/04/2026

18/04/2026

14/04/2026

13/04/2026

07/04/2026

07/04/2026

01/04/2026

30/03/2026

20/03/2026

19/03/2026

07/03/2026

06/03/2026

Address

Opening Hours

Telephone

Website

Alerts

Contact The Practice

Shortcuts

Share

Category